![](/images/Company_Logo/company_logo_default.png)
Nanosyn Inc (AKA: Nanoscale Combinatorial Synthesis inc) Profile last edited on: 12/22/2020
CAGE: 5CNA8
UEI: P6JHGUQWZ2C1
Business Identifier: Drug Discovery Services using nanoscaled compounds Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Multiple
Congr. District: 17
County: Santa Clara
Congr. District: 17
County: Santa Clara
Public Profile
Nanosyn, Inc., a medicinal chemistry and biological services contract research organization, provides Chemistry on Demand services to biotechnology and pharmaceutical companies, and academic institutions worldwide .Chemistry on Demand is a sophisticated technological platform based on Nanosyn's patented techniques which include proprietary methodology, know-how, chemical synthesis, software and instrumentation designed to generate novel, pure, and well characterized compounds. It specializes in design, synthesis, and analysis of small organic compounds for the pharmaceutical and biotechnology industries.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2014 | 1 | NIH | $295,299 | |
Project Title: Small Molecule Neuronal Autophagy Inducers Designed To Block Neurodegeneration To | ||||
2014 | 2 | NIH | $700,000 | |
Project Title: Neuronal Autophagy Inducers as an Approach to Treat Diseases of the Central Nervo |
Key People / Management
Nikolai F Sepetov -- President
Robert Greenhouse
Olga L Issakova -- Executive Vice President
Robert Greenhouse
Olga L Issakova -- Executive Vice President